StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.51−0.05 (-9.39%)

Close on Nov 20, 2026Market cap $11.89MP/E –Yield –

Genenta Science S.p.A. gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Genenta Science S.p.A.

Genenta Science S.p.A. has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Genenta Science S.p.A. figures

See a number that looks wrong?